As of 4:00 p.m. ET on Thursday, OKB (OKB +16.99%) is among the best-performing cryptocurrencies in the market. This native token of the OKB decentralized exchange (one of the more popular such exchanges) has surged by more than 18% over the past 24 hours, propelling it into the top-40 leaderboard of all digital assets by market capitalization. Expand CRYPTO : OKB OKB Today's Change ( 16.99 %) $ 13.30 Current Price $ 91.60 Key Data Points Market Cap $1.9B Day's Range $ 77.33 - $ 117.60 52wk Range $ 38.37 - $ 255.50 Volume 347M Let's dive into what's moving the needle for OKB right now, given the fact that the overall crypto market is down nearly 3% over the same time frame. Indeed, when one project, such as OKB, is outperforming as it is right now, investors should take note. Let's do just that. Why is OKB surging today? Powering one of the fastest-growing decentralized exchanges in the market, OKB is one top tokens that deserves a look on this basis alone. Over the past day, various reports have highlighted significant surges in trading volume on this platform, with roughly $210 million traded over the past 21 hours (nearly 9% of the token's total market capitalization). That's a big deal for those thinking about which decentralized trading platform users are gravitating toward right now. Other key drivers of today's move appeared to be strong institutional buying and staking activity, as reflected in OKB's overall total value locked, which has seen a slight uptick in recent days. I'd like to see more on this front (a TVL of just $1.5 million for a project with a market capitalization near $2 billion isn't significant). That said, it's more about trading volumes for this token, and on that front, the growth story for OKB appears to be progressing well.

Andrii Yalanskyi/iStock via Getty Images In management consulting, which is my background, there is a common question that consultants and corporate leaders try to address together before embarking on new capital allocation: Does your strategy give you the right to win? It is a holistic question, which forces one to take both a helicopter view (geography, sector, market share) and deep-dives (various capabilities, balance sheet, product) to understand whether the business stands a good chance to deliver superior long-term returns by doing what it has been doing so far or by venturing into new areas. The idea is that businesses have to earn their right to win. It can be earned by making choices that are aligned with capabilities/strengths - i.e., "playing on your strengths". Now, how does this fit together with durable and/or retirement income investing? Here are my thoughts. In durable income investing the concept of winning is a combination of a) stable current income streams, b) tangible yields, c) compounding at a meaningful tempo. When thinking about whether the investment strategy gives us the right to win, we have to earn it by aligning our choices (picks) with the businesses that have durable cash flows, predictability and smooth compounding (growth) as their strengths. Plus, we have to make sure that these items are really their strengths and not temporary features due to, say, favorable market conditions or the right cycle. The recent equity CLO ( OXLC ), weaker private credit ( FSCO ) and aggressive yield covered call ETF product ( ULTY ) NAV (and yield) declines serve as good proof. And this can also happen in optically de-risked segments of the market like investment grade telcos ( T ) and equity REITs ( ARE ). Let me now present two investment picks, which, in my view, embody all of the critical elements that should give you, as a durable income investor, the right to win (i.e., compounding cash flows in a smooth and stress-free fashion). Two 5%+ yield ...

Welcome back to Soundbite. After spending two days in the bowels of New York federal court covering the Live Nation antitrust trial without a phone or laptop, I’m back online. Today, we’re taking a look at what’s happened to the YouTube channels for podcasts that went behind Netflix Inc.’s paywall. If any of you will be in Austin for SXSW, invite me to your parties, dinners and talks. (Or let’s just get coffee.) I’m headed out there at the end of next week and some of the following. If you appreciate this kind of work, please support it and subscribe . Reach me through email . Up first, here’s what I’m reading and writing this week. At the Live Nation trial, yesterday was the first day of witness testimony, which was largely spent discussing what happened at the Barclays Center after it switched from Ticketmaster to SeatGeek. The story has it all : a secretly recorded phone call with one of the most powerful executives in music, a Billie Eilish tour and perceived “threats” to multiple arenas. My colleagues will continue to be in the courthouse so follow their coverage, and I’ll keep you updated here as the trial progresses. The Chinese government spent massively in Africa to build a news media empire, but it has a problem: no one is watching . Robert Kyncl, chief executive officer at Warner Music Group Corp., issued a letter to shareholders to get ahead of artificial intelligence doomers who think record labels will be on the losing side of the AI onslaught. “We are actively harnessing AI to win,” he wrote after spelling out the company’s framework for any deal. Amazon.com Inc.’s Audible officially launched a cheaper subscription tier that we broke was being tested almost two years ago. The content on the Wondery+ subscription app is going to be integrated into Audible proper and then shut down. On the other side of the Netflix podcast deals When Netflix first announced that podcasters would bring their videos over to the streaming service, the company made it clear...

The GEO Group ( GEO ) announced that chief financial officer Mark Suchinski will leave the company effective March 31, 2026. Shayn March, currently executive vice president, Finance and Treasurer, will become chief financial officer effective April 1, 2026. More on GEO Group GEO Group: The Stock Remains Highly Sensitive To Policy Dynamics The GEO Group: Out Of Favor, But Many Paths To A Partial Rebound The GEO Group, Inc. 2025 Q4 - Results - Earnings Call Presentation Geo Group outlines $2.9B–$3.1B revenue target for 2026 as new ICE contracts drive record growth Deportation backlash adds fresh uncertainty for DHS contractors

In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So when stocks turn up that see insider buying, and are also top ranked, investors are wise to take notice. One such company is FS KKR Capital Corp (Symbol: FSK), which saw buying by CIO Daniel Pietrzak. Back on February 27, Pietrzak invested $56,250.00 into 5,000 shares of FSK, for a cost per share of $11.25. In trading on Thursday, bargain hunters could buy shares of FS KKR Capital Corp (Symbol: FSK) and achieve a cost basis 2.8% cheaper than Pietrzak, with shares changing hands as low as $10.94 per share. FS KKR Capital Corp shares are currently trading -0.50% on the day. The chart below shows the one year performance of FSK shares, versus its 200 day moving average: Looking at the chart above, FSK's low point in its 52 week range is $10.28 per share, with $22.95 as the 52 week high point — that compares with a last trade of $10.94. By comparison, below is a table showing the prices at which insider buying was recorded over the last six months: Purchased Insider Title Shares Price/Share Value 11/07/2025 Daniel Pietrzak President and CIO 10,000 $15.15 $151,500.00 11/11/2025 Michael C. Forman Chief Executive Officer 10,000 $15.50 $155,000.00 02/27/2026 Daniel Pietrzak President and CIO 5,000 $11.25 $56,250.00 The DividendRank report noted that among the coverage universe, FSK shares displayed both attractive valuation metrics and strong profitability metrics. For example, the recent FSK share price of...

In Brief Hackers have reportedly broken into the networks of the FBI. On Thursday, citing an anonymous source, CNN reported that the breach affected a system used to manage wiretaps and foreign intelligence surveillance warrants. “The FBI identified and addressed suspicious activities on FBI networks, and we have leveraged all technical capabilities to respond,” a bureau spokesperson told TechCrunch, declining to provide more details. This is the latest major breach of U.S. government agencies and American companies in recent times. Last year, Chinese hackers broke into the U.S. Treasury and the National Nuclear Security Administration, which oversees the security of the U.S. nuclear stockpile. All the while, Russian hackers stole sealed records from the U.S. Courts’ filing system. Also, Elon Musk’s DOGE took control of Americans’ personal data, defying longstanding security practices and violating federal protocols, despite a Senator warning that Musk poses national security risks. Meanwhile, the Chinese government hacking group Salt Typhoon has broken into at least 200 U.S. companies, according to the FBI. Some of the companies confirmed to have been hacked include telecommunications providers AT&T and Verizon, as well as Lumen, Charter Communications and Windstream.

Aecon press release ( AEGXF ): Q4 Non-GAAP EPS of C$0.52. Revenue of C$1.54B (+21.3% Y/Y) beats by C$510M . More on Aecon Group Inc. Seeking Alpha’s Quant Rating on Aecon Group Inc. Historical earnings data for Aecon Group Inc. Dividend scorecard for Aecon Group Inc. Financial information for Aecon Group Inc.

格隆汇3月6日｜市场消息：阿拉伯地区各国外交部长将于周日举行紧急会议。

Contineum Therapeutics press release ( CTNM ): Q4 GAAP EPS of -$0.49. Cash, cash equivalents and marketable securities were $262.9 million as of December 31, 2025. Contineum believes its cash resources are sufficient to fund its planned operations through mid-2029. More on Contineum Therapeutics Contineum Therapeutics stock drops as company prices upsized $90 million offering Contineum Therapeutics announces proposed $75M public offering Seeking Alpha’s Quant Rating on Contineum Therapeutics Historical earnings data for Contineum Therapeutics Financial information for Contineum Therapeutics

In trading on Friday, shares of the TLTW ETF (Symbol: TLTW) crossed below their 200 day moving average of $26.30, changing hands as low as $26.15 per share. TLTW shares are currently trading off about 1.1% on the day. The chart below shows the one year performance of TLTW shares, versus its 200 day moving average: Looking at the chart above, TLTW's low point in its 52 week range is $24.74 per share, with $28.60 as the 52 week high point — that compares with a last trade of $26.25. Click here to find out which 9 other ETFs recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In trading on Friday, shares of The Charles Schwab Corporation (Symbol: SCHW) crossed below their 200 day moving average of $72.97, changing hands as low as $68.59 per share. The Charles Schwab Corporation shares are currently trading down about 7.9% on the day. The chart below shows the one year performance of SCHW shares, versus its 200 day moving average: Looking at the chart above, SCHW's low point in its 52 week range is $61.01 per share, with $84.50 as the 52 week high point — that compares with a last trade of $70.39. The SCHW DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In trading on Thursday, shares of the FLDR ETF (Symbol: FLDR) crossed below their 200 day moving average of $50.24, changing hands as low as $50.23 per share. FLDR shares are currently trading down about 0.1% on the day. The chart below shows the one year performance of FLDR shares, versus its 200 day moving average: Looking at the chart above, FLDR's low point in its 52 week range is $49.73 per share, with $50.62 as the 52 week high point — that compares with a last trade of $50.26. Click here to find out which 9 other ETFs recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Omada Health, Inc. press release ( OMDA ): Q4 GAAP EPS of $0.08 beats by $0.13 . Revenue of $76M (+58.3% Y/Y) beats by $6.31M . Financial Outlook Revenue in the range of $312 million to $322 million, with the midpoint representing 22% growth compared with 2025 Adjusted EBITDA in the range of $7 million to $15 million More on Omada Health, Inc. Omada Health, Inc. (OMDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Omada Health expects Q4 revenue to be between $72M and $74M Seeking Alpha’s Quant Rating on Omada Health, Inc. Historical earnings data for Omada Health, Inc. Financial information for Omada Health, Inc.

Heading into the final day of trading, shares of Palantir Technologies (PLTR 0.39%) have jumped 10.8% this week, according to data provided by S&P Global Market Intelligence. The stock is gaining momentum as the U.S. military is engaged in a war with Iran. The U.S. government's fight with another artificial intelligence (AI) firm may also be stoking investor interest in Palantir this week. The power of AI The recent attack on Iran and conflict in the Middle East have spotlighted defense stocks, and Palantir, a provider of AI software to the U.S. government, is among them. Much of investors' focus on Palantir over the last year has been on its ability to move beyond government contracts and grow its commercial business. While the commercial business is growing faster, over half of the company's domestic sales still come from government work, which grew 66% year over year in Q4. Baird Technology Strategist Ted Mortonson commented about the company this week on the Yahoo! Finance "Market Domination" podcast. He noted that, along with the U.S. Department of Defense, the Israeli Defense Force (IDF) uses Palantir software. He noted that the current conflict represents the power of its software "in real time, and also some predictive technology that we never had before." Expand NASDAQ : PLTR Palantir Technologies Today's Change ( -0.39 %) $ -0.60 Current Price $ 152.59 Key Data Points Market Cap $366B Day's Range $ 149.63 - $ 156.38 52wk Range $ 66.12 - $ 207.52 Volume 2M Avg Vol 47M Gross Margin 82.37 % Investors this week also feel that Palantir could benefit from the Defense Department's dispute with AI firm Anthropic, which has been temporarily banned from all U.S. government business. As AI becomes embedded in military organizations and weapon systems, Palantir's role looms ever larger. Investors are likely considering the company's potential global market size and buying the stock, especially given shares are well off their 2026 high of more than $180.

Key Points Palantir's profile as a critical provider of AI software is rising. Its role with the military has been highlighted, and that's not even its fastest growing segment. 10 stocks we like better than Palantir Technologies › Heading into the final day of trading, shares of Palantir Technologies (NASDAQ: PLTR) have jumped 10.8% this week, according to data provided by S&P Global Market Intelligence. The stock is gaining momentum as the U.S. military is engaged in a war with Iran. The U.S. government's fight with another artificial intelligence (AI) firm may also be stoking investor interest in Palantir this week. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » The power of AI The recent attack on Iran and conflict in the Middle East have spotlighted defense stocks, and Palantir, a provider of AI software to the U.S. government, is among them. Much of investors' focus on Palantir over the last year has been on its ability to move beyond government contracts and grow its commercial business. While the commercial business is growing faster, over half of the company's domestic sales still come from government work, which grew 66% year over year in Q4. Baird Technology Strategist Ted Mortonson commented about the company this week on the Yahoo! Finance "Market Domination" podcast. He noted that, along with the U.S. Department of Defense, the Israeli Defense Force (IDF) uses Palantir software. He noted that the current conflict represents the power of its software "in real time, and also some predictive technology that we never had before." Investors this week also feel that Palantir could benefit from the Defense Department's dispute with AI firm Anthropic, which has been temporarily banned from all U.S. government business. As AI becomes embedded in military organizations and weapon systems, Pala...

Heading into the final day of trading, shares of Palantir Technologies (NASDAQ: PLTR) have jumped 10.8% this week, according to data provided by S&P Global Market Intelligence. The stock is gaining momentum as the U.S. military is engaged in a war with Iran. The U.S. government's fight with another artificial intelligence (AI) firm may also be stoking investor interest in Palantir this week. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: The Motley Fool. The power of AI The recent attack on Iran and conflict in the Middle East have spotlighted defense stocks, and Palantir, a provider of AI software to the U.S. government, is among them. Much of investors' focus on Palantir over the last year has been on its ability to move beyond government contracts and grow its commercial business. While the commercial business is growing faster, over half of the company's domestic sales still come from government work, which grew 66% year over year in Q4. Baird Technology Strategist Ted Mortonson commented about the company this week on the Yahoo! Finance "Market Domination" podcast. He noted that, along with the U.S. Department of Defense, the Israeli Defense Force (IDF) uses Palantir software. He noted that the current conflict represents the power of its software "in real time, and also some predictive technology that we never had before." Investors this week also feel that Palantir could benefit from the Defense Department's dispute with AI firm Anthropic, which has been temporarily banned from all U.S. government business. As AI becomes embedded in military organizations and weapon systems, Palantir's role looms ever larger. Investors are likely considering the company's potential global market size and buying the stock, especially given shares are well off their 2026 high of more than $180....

Good morning . Trump says he should help pick Iran’s next leader. JD.com posts its first loss in four years. And Netflix acquires Ben Affleck’s AI filmmaking business. Listen to the day’s top stories . S&P 500 6,830.71 -0.56% Nvidia 183.32 +0.15% Brent 83.91 +3.08% WTI 79.26 +6.12% As Iran edges toward choosing a new leader, Donald Trump says he wants to be personally involved . The US president told Axios that Mojtaba Khamenei—the son of the late Ayatollah—is the likely successor, an outcome he deems “unacceptable.” The war showed little sign of easing , as the Islamic Republic launched a fresh wave of missile and drone strikes across the Gulf. US oil prices came off intraday highs after a report on potential Treasury action to combat rising energy prices . Our Big Take examines satellite images and data that reveal the breadth of destruction to military and civilian targets. The semiconductor sector was roiled by news that the Trump administration is drafting rules that would require US approval for global AI chip sales by Nvidia and companies in the space. Shares across the industry were hammered, sending the S&P 500 lower , with Nvidia falling as much as 2.8% before recovering to close up 0.2%. Just a few weeks after the Supreme Court struck down his sweeping global tariffs, Trump’s brand-new levies are facing a major legal challenge : Two dozen states filed a lawsuit over the president’s new 10% tariffs that took effect last month. The administration already aims to increase the levy to 15% . TCS Is in ‘Advanced’ Talks for More AI Data Centers in India Read the Story As US tariffs reorder supply chains and Trump moves from one military campaign to the next , China offered its answer to a more volatile world: stability . Xi Jinping said Beijing needs to deal with “more complex” conditions and address more deep-rooted challenges in order to achieve economic targets, CCTV reported. BYD is doing all it can to reverse a deepening sales slump in its home market. The ...

ArriVent BioPharma press release ( AVBP ): FY GAAP EPS of -$4.32 beats by $0.05 . As of December 31, 2025, the Company had cash and investments of $312.8 million, which is expected to fund operations into 3Q 2027. Net cash used in operations was $160.6 million and $70.2 million for the years ended December 31, 2025 and 2024, respectively. Research and development expenses were $153.4 million and $79.0 million for the years ended December 31, 2025 and 2024, respectively. The research and development expenses in 2025 include a one-time upfront payment to Lepu Biopharma Co., Ltd. General and administrative expenses were $24.2 million and $15.3 million for the years ended December 31, 2025 and 2024, respectively. More on ArriVent BioPharma ArriVent BioPharma: Its Leading Asset, Furmonertinib, Supports A Cautious Buy ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts Seeking Alpha’s Quant Rating on ArriVent BioPharma Historical earnings data for ArriVent BioPharma Financial information for ArriVent BioPharma

格隆汇3月6日｜美国至3月6日当周外国央行持有美国国债 -93.33亿美元，前值-150.61亿美元。

Key Takeaways The Trump administration is working on new rules to restrict exports of advanced chips, Bloomberg reported. Nvidia, Advanced Micro Devices, and other semiconductor stocks slumped Thursday before paring back losses. Get personalized, AI-powered answers built on 27+ years of trusted expertise. ASK America's chip export rules could get tougher. That hit some big tech stocks today. The Trump administration is working on new rules that could require companies to obtain permission from the government for exports of "virtually all" of their AI accelerators, according to a Bloomberg report. The news weighed on a number of chip stocks during a down day for stocks broadly. Shares of AI chipmaker Nvidia (NVDA), Advanced Micro Devices (AMD), and other semiconductor firms slumped Thursday before paring back losses. Broadcom (AVGO) was a bright spot in the PHLX Semiconductor Sector Index (SOX), logging a nearly 5% gain after a better-than-expected earnings report. Why This Matters to Investors The rules reported by Bloomberg would represent another setback for investors of American AI chipmakers such as Nvidia and AMD, who have been eager to see the companies sell more of their advanced chips to other countries. Nvidia, AMD, and the Bureau of Industry and Security—which oversees semiconductor export controls—did not respond to Investopedia's requests for comment in time for publication. The framework could further limit sales by chipmakers like Nvidia and AMD, the report said, as well as spur a flurry of new export licensing agreements like the ones President Donald Trump brokered with the two companies in recent months. Nvidia and AMD last year won approvals from the Trump administration to export some of their more advanced chips to China in exchange for sharing a cut of their revenues. Still, those sales haven't been easy to land: Nvidia executives said last week that the company has yet to generate any revenue from sales of its Trump-approved H200 chips to China...

Since Warren Buffett announced that he would step down as CEO of Berkshire Hathaway (BRKA +2.74%)(BRKB +2.53%) at the end of 2025, the entire stock market has been speculating on what changes could be coming to the conglomerate. Buffett appointed Greg Abel as the new CEO after Abel spent many years running Berkshire Hathaway Energy. Abel has big shoes to fill and acknowledged as much in his first annual letter to shareholders. Berkshire stock commanded a certain premium, given that most people believe Buffett is the best stock picker of all time. Abel is clearly more than capable of running Berkshire and was hand-picked by Buffett, which should give shareholders some assurances. However, he has a long way to go to earn the same premium and loyalty that his predecessor did. This has led some investors to believe that Berkshire may operate differently under Abel -- for example, by distributing more capital to shareholders. Is the company about to start paying a dividend? He just provided a clue. Not in the near term, but not off the table Berkshire has generated tens of billions in earnings and tremendous free cash flow, but when asked in the past why his company never used that for a dividend, Buffett consistently said he believes he and the company could invest the capital more effectively and generate higher returns for shareholders. With a track record like Buffett's, few have argued. But as I mentioned, Abel does not yet have that same luxury. Many actually suspected that the reason Berkshire has hoarded $370 billion of cash and short-term U.S. Treasury bonds was to start Abel off from a position of strength and allow him to begin paying a dividend. Expand NYSE : BRKB Berkshire Hathaway Today's Change ( 2.53 %) $ 12.32 Current Price $ 499.80 Key Data Points Market Cap $1.1T Day's Range $ 492.54 - $ 500.86 52wk Range $ 455.19 - $ 542.07 Volume 525K Avg Vol 4.8M Gross Margin 23.63 % In his letter to shareholders, Abel wrote: "Our approach to cash dividends continue...

Key Points Warren Buffett never had Berkshire pay a dividend because he believed he and his team could allocate capital more effectively. Berkshire Hathaway stock has long commanded a premium due to Buffett's leadership. The new CEO will not command the same premium, leading some investors to wonder if a dividend might be on the table at some point. 10 stocks we like better than Berkshire Hathaway › Since Warren Buffett announced that he would step down as CEO of Berkshire Hathaway (NYSE: BRKA)(NYSE: BRKB) at the end of 2025, the entire stock market has been speculating on what changes could be coming to the conglomerate. Buffett appointed Greg Abel as the new CEO after Abel spent many years running Berkshire Hathaway Energy. Abel has big shoes to fill and acknowledged as much in his first annual letter to shareholders. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Berkshire stock commanded a certain premium, given that most people believe Buffett is the best stock picker of all time. Abel is clearly more than capable of running Berkshire and was hand-picked by Buffett, which should give shareholders some assurances. However, he has a long way to go to earn the same premium and loyalty that his predecessor did. This has led some investors to believe that Berkshire may operate differently under Abel -- for example, by distributing more capital to shareholders. Is the company about to start paying a dividend? He just provided a clue. Not in the near term, but not off the table Berkshire has generated tens of billions in earnings and tremendous free cash flow, but when asked in the past why his company never used that for a dividend, Buffett consistently said he believes he and the company could invest the capital more effectively and generate higher returns for shareholders. With a track record li...

Thursday, March 5, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corp. (XOM), Palantir Technologies Inc. (PLTR) and AstraZeneca PLC (AZN), as well as two micro-cap stocks Gencor Industries, Inc. (GENC) and Hour Loop, Inc. (HOUR). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>> Ahead of Wall Street The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning. You can read today's AWS here >>> Parade of Econ Data: Jobless Claims, Productivity & More Today's Featured Research Reports Exxon Mobil’s shares have outperformed the Zacks Oil and Gas - Integrated - International industry over the past six months (+38.5% vs. +32.1%). The company’s high-value assets in the Permian Basin and Guyana drive robust production growth, doubling upstream earnings since 2019. The company continues to achieve record production in both key oil-producing regions. With a lower exposure to debt capital, XOM supports steady cash flows, dividends, buybacks and investments in high-return projects. Expansion in low-carbon tech, including Baytown's hydrogen facility, positions it for future growth. ExxonMobil reported strong fourth-quarter earnings driven by higher oil equivalent production volumes. However, crude prices are ...

Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca Nasdaq

Thursday, March 5, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corp. (XOM), Palantir Technologies Inc. (PLTR) and AstraZeneca PLC (AZN), as well as two micro-cap stocks Gencor Industries, Inc. (GENC) and Hour Loop, Inc. (HOUR). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>> Ahead of Wall Street The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning. You can read today's AWS here >>> Parade of Econ Data: Jobless Claims, Productivity & More Today's Featured Research Reports Exxon Mobil’s shares have outperformed the Zacks Oil and Gas - Integrated - International industry over the past six months (+38.5% vs. +32.1%). The company’s high-value assets in the Permian Basin and Guyana drive robust production growth, doubling upstream earnings since 2019. The company continues to achieve record production in both key oil-producing regions. With a lower exposure to debt capital, XOM supports steady cash flows, dividends, buybacks and investments in high-return projects. Expansion in low-carbon tech, including Baytown's hydrogen facility, positions it for future growth. ExxonMobil reported strong fourth-quarter earnings driven by higher oil equivalent production volumes. However, crude prices are ...

Why Is Palantir Stock Bouncing This Week? Nasdaq

asiandelight/iStock via Getty Images Geopolitical shocks and market complacency rarely coexist for long. Yesterday, the broader markets were in the green, as investors suddenly remembered that wars in the past didn't pressure markets in a meaningful way. MSCI I fully agree with this rationale. So, why did I short the U.S. markets with (highly risky) put options this week? First, the geopolitical tensions in the Middle East have very little to do with it. Yes, Brent ( CO1:COM ) is up, and gas pumps in the U.S. are already showing an increase, which is likely to impact the discretionary income for the bottom-end consumers of the K-shaped economy, pressuring cyclicals. This is just the tip of the iceberg. I’m also short private credit firms as the fundamentals of most asset management firms look largely intact. Wait what! Read that again: I'm shorting private credit firms as fundamentals are largely intact ... Sounds counterintuitive, right? I mean, if fundamentals are mostly intact, and the stock price is tanking, one should buy the weakness, right? In my view, the answer depends on the timeframe. If we are talking about a multiyear timeframe, then absolutely yes, be my guest. However, in the near term, I don't see a strong catalyst to revive the sentiment in private credit, especially in H1 this year, after multiple cockroaches have recently been spotted in the private credit kitchen. In this piece, I explain the rationale of my short bet and why I still think the rating for the broader markets remains a hold. To be clear, I'm not an alarmist. I expect a small 10% correction in the SPDR® S&P 500 ETF Trust ( SPY ) in H1 this year, which I believe will be preceded by a run toward new highs. In fact, my other portfolio is still largely invested in industrials and a very small amount of tech stocks. So, I'm not panic selling, at least, not yet. No Signs Of De-escalation So Far As I'm writing this piece in the pre-market session of March 5, I see no signs that suggest a c...

Key Points Spero Alex sold 4,790 shares indirectly via trust for a total of ~$316,000 on Feb. 25, 2026, at a weighted average price around $66.00 per share. This disposition represented 100% of Mr. Alex's indirect holdings, reducing his indirect ownership position to zero post-transaction. All shares were held through the Alex Family Trust, with no direct or derivative holdings involved in this sale. 10 stocks we like better than Cheesecake Factory › Spero Alex, Executive Vice President of Operations at The Cheesecake Factory (NASDAQ:CAKE), reported the indirect sale of 4,790 shares in an open-market transaction valued at approximately $316,000 according to the SEC Form 4 filing. Transaction summary Metric Value Shares sold (indirect) 4,790 Transaction value $316,000 Transaction value based on SEC Form 4 weighted average purchase price ($66.00); post-transaction value was $0.00 as no holdings remained after the sale. Key questions What portion of Spero Alex's total Cheesecake Factory holdings was impacted by this transaction? This transaction represented a 100% reduction in Mr. Alex’s indirect ownership via the Alex Family Trust, with no direct or derivative shares noted following the sale. This transaction represented a 100% reduction in Mr. Alex’s indirect ownership via the Alex Family Trust, with no direct or derivative shares noted following the sale. What was the market context for the sale? The transaction executed at a weighted average price around $66.00 per share, with Cheesecake Factory shares closing at $65.94 on Feb. 25, 2026; the stock had appreciated 25.27% over the prior year as of the transaction date. The transaction executed at a weighted average price around $66.00 per share, with Cheesecake Factory shares closing at $65.94 on Feb. 25, 2026; the stock had appreciated 25.27% over the prior year as of the transaction date. How does this sale compare to Mr. Alex's past activity? This was Mr. Alex’s only open-market sale, matching the prior median and...

The post A Passive ETF, Built for Your Investment Goals. Motley Fool Asset Management Expands Investment Offerings to Diversify Portfolios. by Benzinga Contributors appeared first on Benzinga . Visit Benzinga to get more great content like this. Benzinga Money is a reader-supported publication. We may earn a commission from the advertisers associated with this article. Read our Advertiser Discloser . Every investor has their own goals. Some are looking to perfect the long game, while others are looking to take on extra risk in exchange for future growth. Regardless of what bucket you fall in, your investment portfolio should reflect your goals. That’s the philosophy behind Motley Fool Asset Management’s newest factor ETF offerings. Each passive ETF offers a growth-oriented alternative to broad index funds, allowing investors to diversify their portfolio based on their investment goals. The funds are composed of U.S. companies vetted and rated by analysts from The Motley Fool, LLC based on quality, risk, and growth potential. Put professional analysts’ highest-conviction stock picks to work for your portfolio, all with the ease and convenience of an ETF. A Closer Look at Motley Fool Asset Management’s Newest ETFs Each of Motley Fool Asset Management’s newest ETFs are built on the “Foolish” investment philosophy of buying and holding high-quality stocks for long periods of time. Here’s a closer look at each of the ETFs, and the type of investor they might be good for: Motley Fool Innovative Growth Factor ETF (MFIG) Targets companies with accelerating profitability and innovation, measured through a proprietary Innovative Growth Composite Score based on gross profit growth, growth acceleration, and investment in intangible assets such as R&D, brand, and human capital. Good for: Those who have a higher risk tolerance and are seeking higher return potential. Motley Fool Value Factor ETF (MFVL) Focused on attractively valued companies identified through adjusted fundament...

Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. (Source: Bloomberg)